NEW YORK (GenomeWeb News) – Decode Genetics has received notification from the Nasdaq Stock Market that the firm's common stock will be suspended from trading as of the open of business tomorrow.

The Iceland-based firm also said that documents will be filed with the US Securities and Exchange Commission, which will remove the firm's common stock from listing on Nasdaq.

Decode said that it is possible its stock will be traded thereafter on the Pink Sheets, but that depends if there is a market maker for the shares.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times Magazine writes that proteomics might be better poised than genomics to say when someone is falling ill.

Bloomberg profiles IndieBio, a startup incubator for the life sciences.

In an editorial, Nature calls for the end to the exploitation of foreign postdocs.

In Nucleic Acids Research this week: collection of epigenome-wide association study data, updated BloodSpot database, and more.